← Back to Search

Storytelling Through Music for Grief in Bereaved Parents

N/A
Recruiting
Led By Carolyn Phillips, PhD
Research Sponsored by University of Texas at Austin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years old
bereaved parent of a child who died from cancer (ages<39 years)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately post-intervention and 1-month post-intervention
Awards & highlights

Study Summary

This trial studies whether a storytelling through music intervention can help bereaved parents cope with the death of their child from cancer.

Who is the study for?
This study is for parents over 18 who have lost a child to cancer (under 39 years old) between 6 months and 5 years ago. Participants must be able to read and speak English, have internet access, and the ability to use Zoom for interviews and REDCap surveys.Check my eligibility
What is being tested?
The trial tests 'Storytelling Through Music' (STM), a six-week program combining storytelling, writing, and music. It aims to help bereaved parents cope by creating a legacy piece that honors their child's memory.See study design
What are the potential side effects?
There are no direct physical side effects expected from this intervention as it involves emotional support through creative expression. However, discussing grief can potentially lead to temporary increases in emotional distress.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I am a parent who lost a child under 39 years old to cancer.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately post-intervention and 1-month post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately post-intervention and 1-month post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Intervention Acceptability
Intervention Feasibility
Study Feasibility
Secondary outcome measures
Mean Change from Baseline in Anxiety Scores at 6 weeks and 10 weeks
Mean Change from Baseline in Continuing Bonds Scores at 6 weeks and 10 weeks
Mean Change from Baseline in Depression Scores at 6 weeks and 10 weeks
+6 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Storytelling Through MusicExperimental Treatment1 Intervention
Participants will be randomized to either the "Storytelling Through Music" (STM) experimental arm or the waitlist control arm. STM is a six-week intervention that utilizes storytelling, reflective writing, self-care skills (i.e., breathing exercises, meditation, self-compassion, body scans), and songwriting. The intervention is delivered online and in a group setting. Online delivery provides convenience to participants, and the group setting provides an environment of people with shared experiences, which has been shown to decrease social isolation and feelings of being alone in their emotional experience. By the end of the intervention, participants will have written a short story and a song based on their story.
Group II: Waitlist ControlActive Control1 Intervention
Participants will receive the same "Storytelling Through Music" intervention once data collection from the experimental arm is complete.

Find a Location

Who is running the clinical trial?

University of Texas at AustinLead Sponsor
353 Previous Clinical Trials
81,214 Total Patients Enrolled
Carolyn Phillips, PhDPrincipal InvestigatorUniversity of Texas at Austin
1 Previous Clinical Trials
40 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What qualifications must someone have in order to take part in this trial?

"To make the cut for this trial, potential participants need to be diagnosed with pediatric cancer and aged between 18 and 99. This clinical research is only granting admission to a maximum of 30 individuals."

Answered by AI

How many participants are involved in the current experiment?

"Affirmative. Clinicaltrials.gov data verifies that this clinical trial, initially posted on May 1st 2023, is actively recruiting patients. 30 individuals are sought to take part at a single site of the trial."

Answered by AI

Is there an age cutoff for enrollment in this clinical experiment?

"This trial is limited to individuals aged between 18 and 99. However, there are seperate trials for those under the age of 18 (53) and over 65 (25)."

Answered by AI

Is enrollment for this clinical inquiry still open?

"Correct. Records on clinicaltrials.gov demonstrate that, since its inception on May 1st 2023, this trial has been actively seeking participants to enroll in the study at a single location and is hoping for around 30 enrollees total."

Answered by AI

What key goals are the researchers aiming to accomplish through this clinical trial?

"The primary goal of this research project, which will be observed for the duration of 6 weeks post-intervention, is to establish Intervention Feasibility. Secondary objectives that need to be evaluated include Mean Change from Baseline in Depression Scores at 6 and 10 Weeks (measured using PROMIS' 8a Short Form with scores ranging between 8-40; higher values represent a greater severity), Quality of Life Scores at 6 and 10 Weeks (using PROMIS' 10 item scale where 5 is minimum score & 50 maximum; high numbers signify more sleep disturbances) , and Sleep Disturbance Scores at 6 and 10 Weeks (utilising"

Answered by AI
~14 spots leftby Apr 2025